Given the growing knowledge on the central role of HOX genes in NPM1c pathogenesis and the interaction with the MLL chromatin complex, recent studies have leveraged the use of small molecule inhibitors of the MLL co-factor menin to target NPM1-mutated AML [106,107,108]. Here, NPM1 is linked to acute myeloid leukemia.